hr 2435Bill

Gluten in Medicine Disclosure Act of 2021

To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.

Introduced on April 8, 2021

House
Senate
President